Biohaven (BHVN) Times Interest Earned (2021 - 2026)
Biohaven (BHVN) posted Times Interest Earned of -$11.97 for Q1 2026, down 333.42% sequentially from -$2.76 in Q3 2025, and down 639.26% YoY from $2.22 in Q1 2025.
Biohaven (BHVN) Times Interest Earned (2021 - 2026) Analysis & Trends
Biohaven has reported Times Interest Earned for 6 years, with the latest figure at -$11.97 in Q1 2026.
- Quarterly Times Interest Earned fell 639.26% year-over-year to -$11.97 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.05 (down 789.72% YoY) and the FY2025 annual result came in at -$2.38, up 18.37% from the prior year.
- Times Interest Earned eased to -$11.97 in Q1 2026 per BHVN's latest filing, from -$2.76 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.36 in Q1 2024 and troughed at -$1285.4 in Q3 2023.
- A 5-year average of -$135.65 and a median of -$2.76 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned tumbled 11926.26% in 2023, then soared 99.97% in 2024.
- Over 5 years, Times Interest Earned stood at -$0.99 in 2022, then soared by 40.02% to -$0.59 in 2023, then declined by 5.55% to -$0.63 in 2024, then slumped by 341.7% to -$2.76 in 2025, then sank by 333.42% to -$11.97 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$11.97, -$2.76, and -$3.71 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | -1.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.65 |
| Mar 31, 2026 | -11.97 |
| Sep 30, 2025 | -2.76 |
| Jun 30, 2025 | -3.71 |
| Mar 31, 2025 | -1.62 |
| Dec 31, 2024 | -0.63 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -1.30 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | -0.59 |
| Sep 30, 2023 | -1,285.43 |
| Jun 30, 2023 | -356.10 |
| Mar 31, 2023 | -238.60 |
| Dec 31, 2022 | -0.99 |
| Sep 30, 2022 | -10.69 |
| Jun 30, 2022 | -119.53 |
| Dec 31, 2021 | -0.94 |